Novel vaccine antigens for Streptococcus pyogenes

化脓性链球菌的新型疫苗抗原

• 批准号: 443655
• 负责人: McCormick John K
• 金额: $ 58.24万
• 依托单位: University of Western Ontario
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-04-01 至 2026-04-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=443655&lang=en
• 关键词: Bacterial Toxins; Bacteriology; Infection; Streptococcus Pyogenes; Vaccines

Streptococcus pyogenes is a prominent bacterial pathogen that only infects humans naturally and is responsible for over 500,000 deaths each year. Despite this massive burden of human disease, we have a poor understanding of how our immune system can inhib

化脓性链球菌是一种主要的细菌病原体，仅自然感染人类，每年造成超过50万人死亡。尽管人类疾病的负担如此沉重，我们对免疫系统如何抵抗疾病的理解却很少。